Effects of the inhibition of cytosolic phospholipase A 2α in non-small cell lung cancer cells

Journal of Cancer Research and Clinical Oncology

Volumn 138, Issue 5, 2012, Pages 827-835

  Sundarraj, Shenbagamoorthy ^a   Kannan, Soundarapandian ^a   Thangam, Ramar ^b   Gunasekaran, Palani ^b  

^a BHARATHIAR UNIVERSITY   (India)

^b Institute of Preventive Medicine   (India)

Author keywords

Cytosolic phospholipase A 2 Alpha; Immunohistochemistry; Non small cell lung carcinoma; Pyrrolidine 2; Western blot

Indexed keywords

CYTOSOLIC PHOSPHOLIPASE A2; CYTOSOLIC PHOSPHOLIPASE A2 ALPHA; PYRROLIDINE 2; PYRROLIDINE DERIVATIVE; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; ENZYME INHIBITOR; PHOSPHOLIPASE A2 GROUP IV; PYRROLIDINE;

ADENOCARCINOMA; ARTICLE; CANCER CELL; CELL DIFFERENTIATION; CELL GROWTH; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; ENZYME ACTIVITY; ENZYME INHIBITION; FEMALE; GROWTH INHIBITION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG NON SMALL CELL CANCER; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SQUAMOUS CELL CARCINOMA; CANCER STAGING; CELL DEATH; CYTOSOL; DRUG ANTAGONISM; DRUG EFFECT; DRUG SCREENING; ENZYMOLOGY; LUNG TUMOR; METABOLISM; PATHOLOGY; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; CARCINOMA, NON-SMALL-CELL LUNG; CELL DEATH; CELL LINE, TUMOR; CELL PROLIFERATION; CYTOSOL; DRUG EVALUATION, PRECLINICAL; ENZYME INHIBITORS; GROUP IV PHOSPHOLIPASES A2; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; NEOPLASM STAGING; PYRROLIDINES;

EID: 84862293064     PISSN: 01715216     EISSN: 14321335     Source Type: Journal    
DOI: 10.1007/s00432-012-1157-7     Document Type: Article

References (38)

1. Blaine SA, Wick M, Dessev C et al (2001) Induction of cPLA2 in lung epithelial cells and Non-small cell lung cancer is mediated by spl and c-Jun. J Biol Chem 276:42737-42743
2. Conde-Frieboes K, Renolds LJ, Lio YC et al (1996) Activated ketones as inhibitors of intracellular Ca2?-dependent and Ca2?-independent phospholipase A2. J Am Chem Soc 118:5519-5525 (Pubitemid 26233638)
3. Dannenberg AJ, Altorki NK, Boyle JO et al (2001) Cyclooxygenase 2: a pharmacological target for the prevention of cancer. Lancet Oncol 2:544-551 (Pubitemid 33586867)
4. Demberg J, Samuelsson A, Hugander A et al (1998) Gene expression of Cyclooxygenase-2, group II and Cytosolic phospholipase A2 in human colorectal cancer. Anticancer Res 18:3283-3287 (Pubitemid 28546447)
5. Fujishima H, Sanchez Mejia RO, Bingham CO III et al (1999) Cytosolic phospholipaseA2 is essential for both the immediate and the delayed phases of eicosanoid generation in mouse bone marrow-derived mast cells. Proc Natl Acad Sci USA 96:4803-4807 (Pubitemid 29214492)
6. Ghomashchi F, Stewart A, Hefner Y et al (2001) A pyrrolidine-based specific inhibitor of cytosolic phospholipase A2a blocks arachidonic acid release in a variety of mammalian cells. Biochim Biophys Acta 1513:160-166 (Pubitemid 32706413)
7. Ghosh M, Tucker DE, Burchett SA et al (2006) Properties of the Group IV phospholipase A2 family. Prog Lipid Res 45:487-510
8. Han C, Demetris AJ, Michalopoulos G, Shelhamer JH, Wu T (2002) 85-kDa cPLA(2) plays a critical role in PPAR-mediated gene transcription in human hepatoma cells. Am J Physiol Gastrointest Liver Physiol 282:G586-G597 (Pubitemid 34651637)
9. Heasley LE, Thaler S, Nicks M et al (1997) Induction of cytosolic phospholipase A2 by oncogenic Ras in human nonsmall cell lung cancer. J Biol Chem 272:14501-14504 (Pubitemid 27251707)
10. Hirabayashi T, Shimizu T (2000) Localization and regulation of cytosolic phospholipase A2. Biochim Biophys Acta 1488:124-138
11. Hoeck WG, Ramesha CS, Chang DJ et al (1993) Cytoplasmic phospholipase A2 activity and gene expression are stimulated by tumor necrosis factor: dexamethasone blocks the induced synthesis. Proc Natl Acad Sci USA 90:4475-4479 (Pubitemid 23148927)
12. Hughes-Fulford M, Tjandrawinata RR, Li CF et al (2005) Arachidonic acid, an x-6 fatty acid, induces cytoplasmic phospholipaseA2 in prostate carcinoma cells. Carcinogenesis 26:1520-1526 (Pubitemid 41236045)
13. Ikawa H, Kamitani H, Calvo BF et al (1999) Expression of 15- lipoxygenase-1 in human colorectal cancer. Cancer Res 59:360-366 (Pubitemid 29048868)
14. Jackson BA, Goldstein RH, Roy R et al (1993) Effects of transforming growth factor b and interleukin-1 b on expression of cyclooxygenase 1 and 2 and phospholipase A2 mRNA in lung fibroblasts and endothelial cells in culture. Biochem Biophys Res Commun 197:1465-1474 (Pubitemid 24042787)
15. Jiang J, Neubauer BL, Graff JR et al (2002) Expression of group IIA secretory phospholipase A2 is elevated in prostatic intraepithelial neoplasia and adenocarcinoma. Am J Pathol 160:667-671 (Pubitemid 34160344)
16. Korystov YN, Shaposhnikova VV, Levitman M et al (1998) The effect of inhibitors of arachidonic acid metabolism on proliferation and death of tumor cells. FEBS Lett 431:224-226 (Pubitemid 28334221)
17. Lagorce-Pages C, Paraf F, Wendum D et al (2004) Expression of inflammatory secretory phospholipase A2 and cytosolic phospholipase A2 in premalignant and malignant Barrett's oesophagus. Virchows Arch 444:426-435 (Pubitemid 38703759)
18. Lappas M, Permezel M, Georgiou HM et al (2004) Regulation of phospholipase isozymes by nuclear factor-jB in human gestational tissues in vitro. J Clin Endocrinol Metab 89:23650-23672
19. Laye JP, Gill JH (2003) Phospholipase A2 expression in tumors: a target for therapeutic intervention. Drug Discov Today 8:710-716 (Pubitemid 36970002)
20. Lehr M, Griessbach K (2000) Involvement of different protein kinases and phospholipases A2 in phorbol ester (TPA)-induced arachidonic acid liberation in bovine platelets. Mediat Inflamm 9:31-34 (Pubitemid 30399115)
21. Meyer AM, Dwyer-Nield LD, Hurteau GJ et al (2004) Decreased lung tumorigenesis in mice genetically deficient in cytosolic phospholipase A2. Carcinogenesis 25:1517-1524 (Pubitemid 39162717)
22. Ono T, Yamada K, Chikazawa Y et al (2002) Characterization of a novel inhibitor of cytosolic phospholipase A2 alpha, pyrrophenone. Biochem J 363:727-735 (Pubitemid 34526393)
23. Osterstrom A, Dimberg J, Fransen K et al (2002) Expression of Cytosolic and group X secretary phospholipase A2 genes in human colorectal adenocarcinomas. Cancer Lett 182:175-182 (Pubitemid 34621181)
24. Patel I, Singh J, Niknami M et al (2008) Cytosolic phospholipase A2: a potential therapeutic target for prostate cancer. Clinical Cancer Res 14:8070-8079
25. Pawliczak R, Han C, Huang X-L et al (2002) 85-kDa cytosolic phospholipase A2 mediates peroxisome proliferator-activated receptor gamma activation in human lung epithelial cells. J Biol Chem 277:33153-33163 (Pubitemid 34984833)
26. Pidgeon GP, Kandouz M, Meram A et al (2002) Mechanisms controlling cell cycle arrest and induction of apoptosis after 12-lipoxygenase inhibition in prostate cancer cells. Cancer Res 62:2721-2727 (Pubitemid 34462758)
27. Pirianov G, Danielsson C, Carlberg C et al (1999) Potentiation by vitamin D analogs of TNFa and ceramide induced apoptosis in MCF 7cells is associated with activation of cPLA2. Cell Death Differ 6:890-901 (Pubitemid 29488087)
28. Sawaoka H, Tsuji S, Tsujii M et al (1999) Cyclooxygenase inhibitors suppress angiogenesis and reduce tumor growth in vivo. Lab Invest 79:1469-1477 (Pubitemid 30013912)
29. Seno K, Okuno T, Nishi K et al (2000) Pyrrolidine inhibitors of human cytosolic phospholipase A2. J Med Chem 43:1041-1044 (Pubitemid 30173729)
30. Seno K, Okuno T, Nishi K et al (2001) Pyrrolidine inhibitors of human cytosolic phospholipase A2. Part 2: synthesis of potent and crystallized 4-triphenylmethylthio derivative pyrrophenone. Bio Org Med Chem Lett 11:587-590 (Pubitemid 32165238)
31. Shappell SB, Gupta RA, Manning S et al (2001) 15SHydroxyeicosatetraenoic acid activates peroxisome proliferator-activated receptor gamma and inhibits proliferation in PC3 prostate carcinoma cells. Cancer Res 61:497-503 (Pubitemid 32128606)
32. Sundarraj S, Kannan S (2010) Immunohistochemical expression of cytosolic phospholipase A2a in nonsmall cell lung carcinoma. Asian Pacific J Cancer Prev 11:1367-1372
33. Sved P, Scott KF, McLeod D et al (2004) Oncogenic action of secreted phospholipase A2 in prostate cancer. Cancer Res 64:6934-6940 (Pubitemid 39331002)
34. Tang DG, Guan KL, Li L et al (1997) Suppression of W256 carcinosarcoma cell apoptosis by arachidonic acid and other polyunsaturated fatty acids. Int J Cancer 72:1078-1087 (Pubitemid 27433575)
35. Wendum D, Svrcek M, Rigau V et al (2003) COX-2, inflammatory secreted PLA2 and cytoplasmic PLA2 protein expression in small bowel adenocarcinomas compared with colorectal adenocarcinomas. Mod Pathol 16:130-136 (Pubitemid 36245744)
36. Wendum D, Comperat E, Boelle PY et al (2005) Cytoplasmic phospholipase A2 alpha overexpression in stromal cells is correlated with angiogenesis in human colorectal cancer. Mod Pathol 18:212-220 (Pubitemid 40188628)
37. Wu T, Han C, Lunz JG III et al (2002) Involvement of 85-kd cytosolic phospholipase A2 and cyclooxygenase-2 in the proliferation of human cholangiocarcinoma cells. Hepatology 36:363-373 (Pubitemid 34810355)
38. Zhu YM, Azahri NS, Yu DC, Woll PJ (2008) Effect of COX 2 inhibitions on expression of vascular endothelial growth factor and interleukin-8 in lung cancer cells. BMC Cancer 8:218